As shown in Table 2, subjects identified with high risk of respective cancers received fecal occult blood test (FOBT) and/or rectal exam as initial screening tests for colorectal cancer, had FOBT for gastric cancer, alpha-fetoprotein (AFP) and ultrasonic testing for liver cancer, chest X-ray for lung cancer, Pap smears for cervix uteri cancer, and clinical breast examination (CBE) and thermal texture maps (TTMs) for breast cancer. The gene discussed is AFP; the disease is lung carcinoma.